SIME DIAGNOSTICS LIMITED
Research and experimental development on biotechnology
SIME DIAGNOSTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
43 Manchester Street London W1U 7LP England
Full company profile for SIME DIAGNOSTICS LIMITED (08881197), an active life sciences and medical technology company based in London, England. Incorporated 7 Feb 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Cash in Bank
£610.99k
Net Assets
£4.63M
Total Liabilities
£52.17k
Turnover
N/A
Employees
7
Debt Ratio
1%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Mar Year End | 2024 31 Mar Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Kunst, Gregory Daniel | Director | American | United States | 4 Dec 2025 | Active |
| Petra Argent | Secretary | Unknown | Unknown | 21 Nov 2016 | Active |
See all 13 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Agnar Thor Höskuldsson
Ceased 20 Dec 2018
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 3 Mar 2026 | Capital | Allotment of shares (GBP 237.5929) on 26 Feb 2026 | |
| 14 Feb 2026 | Confirmation Statement | Confirmation statement made on 7 Feb 2026 with updates | |
| 28 Jan 2026 | Officers | Termination of Agnar Thor Höskuldsson as director on 22 Jan 2026 | |
| 28 Jan 2026 | Capital | Allotment of shares (GBP 231.8227) on 4 Dec 2025 | |
| 28 Jan 2026 | Officers | Termination of Manuel Pinuela Rangel as director on 22 Jan 2026 |
Allotment of shares (GBP 237.5929) on 26 Feb 2026
Confirmation statement made on 7 Feb 2026 with updates
Termination of Agnar Thor Höskuldsson as director on 22 Jan 2026
Allotment of shares (GBP 231.8227) on 4 Dec 2025
Termination of Manuel Pinuela Rangel as director on 22 Jan 2026
Recent Activity
Latest Activity
Allotment of shares (GBP 237.5929) on 26 Feb 2026
3 months ago on 3 Mar 2026
Confirmation statement made on 7 Feb 2026 with updates
3 months ago on 14 Feb 2026
Termination of Agnar Thor Höskuldsson as director on 22 Jan 2026
4 months ago on 28 Jan 2026
Allotment of shares (GBP 231.8227) on 4 Dec 2025
4 months ago on 28 Jan 2026
Termination of Manuel Pinuela Rangel as director on 22 Jan 2026
4 months ago on 28 Jan 2026